Allergan plc (AGN)
(Delayed Data from NYSE)
$145.81 USD
+1.56 (1.08%)
Updated May 3, 2019 04:01 PM ET
After-Market: $145.88 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$145.81 USD
+1.56 (1.08%)
Updated May 3, 2019 04:01 PM ET
After-Market: $145.88 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Pharma Stock Outlook - July 2015
by Arpita Dutt
Mergers, acquisitions and deals continue to take center-stage in the pharma sector. While 2014 turned out to be one of the most active years in the pharma sector where mergers and acquisitions and licensing agreements are concerned, the trend continues this year as well.
The Parade of Weak Earnings Reports Continues
by Sheraz Mian
We haven't had much earnings growth lately and the growth rate for Q1 is expected to turn negative.
Revenue Weakness Stands Out in Q1 Earnings Season
by Sheraz Mian
The earnings picture outside the Finance sector isn't quite reassuring.
Q1 Earnings Season Ramps Up
by Sheraz Mian
We have enough bellwethers from other sectors to give us a good sense of this earnings season.
Q1 Earnings Season in Spotlight as Alcoa (AA) Reports Results
by Sheraz Mian
Market participants will be looking for Alcoa's commentary about the state of global aluminum demand.
PEG Ratio vs. the P/E Ratio
by Kevin Matras
Kevin Matras compares the PEG ratio to the P/E ratio and shows how to use them both for finding classically undervalued stocks with market beating growth rates. Highlighted stocks include ACT, ALDW, LCI, TTM and UAL.
What is Your Stock's Earnings Yield?
by Kevin Matras
Kevin Matras talks about a stock's Earnings Yield and how to use it. Highlighted stocks include ACT, AHL, ANW, TRN and URI.